Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic ColitisStephan Miehlke, Wolfgang Kruis, Juozas Kupčinskas et al.|Gastroenterology|2018Cited by 70
Sa1760 - Novel Microscopic Colitis Disease Activity Index Reflects High Efficacy of Oral Once Daily Budesonide Treatment in Lymphocytic Colitis: Post-HOC Analysis of a Randomized, Double-Blind, Double-Dummy, Multicenter, TrialStephan Miehlke, Andreas Münch, Daniela E. Aust et al.|Gastroenterology|2018Cited by 0
816 - Oral Once Daily Budesonide Granules Induce Clinical Remission in Lymphocytic Colitis and Improve Quality of Life: A Randomized, Double-Blind, Double-Dummy Multicenter TrialStephan Miehlke, Andreas Münch, Daniela E. Aust et al.|Gastroenterology|2018Cited by 0